Exploiting Epigenetic Dependencies of Notch1 for Clinical Benefit |
University of Colorado Denver / Patricia Ernst, Ph.D. |
Innovation Grants |
2014 |
Colorado |
Targeting the Six1/Eya Transcriptional Complex to Inhibit Pediatric Sarcomas |
University of Colorado Denver / Heide Ford, Ph.D. |
Innovation Grants |
2014 |
Colorado |
Neurocognitive Assessments within COG: An Intensive, Integrated Model for Successfully Evaluating Children with High-Risk ALL |
Children’s Research Institute / Kristina Hardy, PhD |
Psychosocial Grants |
2014 |
District of Columbia |
Development of AAV Vectors for Efficient Targeting and Elimination of Osteosarcoma Tumor-Initiating Cells |
University of Florida / Steven Ghivizzani, Ph.D. |
Innovation Grants |
2014 |
Florida |
Phase I Trial of Indoximod in Combination with Temozolomide-based Therapy for Children with Progressive Primary Brain Tumors |
Georgia Health Sciences University Research Institute, Inc. / Theodore Johnson, M.D., Ph.D. |
Bio-Therapeutic Impact Award |
2014 |
Georgia |
Molecular Mechanism and Development of Therapeutic Strategies Targeting MYCN-induced Calcium Signaling in Advanced Neuroblastoma |
University of Hawaii at Hilo / Ingo Koomoa-Lange, PhD |
Young Investigator Grants |
2014 |
Hawaii |
DNA Methylation Inhibitor Therapy for Testicular Germ Cell Tumors |
University of Illinois, Urbana-Champaign / Michael Spinella, Ph.D. |
Reach Grants |
2014 |
Illinois |
Targeting MYC/MYCN-driven Transcriptional Amplification in Pediatric Cancer |
Dana-Farber Cancer Institute / Rani George, M.D., Ph.D. |
Innovation Grants |
2014 |
Massachusetts |
Development of a Screening Module to Assess Sibling-Related Psychosocial Risk in Families of Children with Cancer |
Boston University / Kristin Long, PhD |
Psychosocial Grants |
2014 |
Massachusetts |
Targeted Therapy for Core Binding Factor Leukemia |
University of Massachusetts Medical School / John Pulikkan, PhD |
Young Investigator Grants |
2014 |
Massachusetts |